Withdrawal attribution becomes difficult when several sedative medicines change together.
What the supplied source reports
The two-center prospective cohort followed 54 ventilated adults exposed to opioids for more than seventy-two hours. Investigators assessed opioid withdrawal during weaning and reported an incidence of 16.7%, with a wide confidence interval. Longer opioid exposure and higher cumulative dose were observed in withdrawal cases but were not statistically significant.
Limits of the evidence
The endpoint was opioid withdrawal, not a validated estimate of benzodiazepine withdrawal. The small sample limited precision, and overlapping symptoms can arise from critical illness, pain or changes in other medicines. An exposure difference without statistical support should not be presented as an established risk factor.
Implications for expert analysis
For reviewing agitation after ICU weaning, reconstruct changes in opioids and benzodiazepines separately. Retain the diagnostic criteria and competing explanations. This paper supports recognition of iatrogenic withdrawal while leaving the source of an individual patient’s symptoms to a detailed chronology.
Source and related reading
Source: Publication PMC5581799, read from the supplied PDF. Applications to expert analysis are interpretation.
Related reading: Alcohol-Related Readmission Study May Also Reflect Withdrawal Severity.
Leave a Reply